Literature DB >> 18330570

Consolidation radioimmunotherapy of follicular lymphoma: a step towards cure?

Jean-François Chatal, Françoise Kraeber-Bodéré, Jacques Barbet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18330570     DOI： 10.1007/s00259-008-0727-z

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  18 in total

1.  Phase II trial of CHOP chemotherapy followed by tositumomab/iodine I-131 tositumomab for previously untreated follicular non-Hodgkin's lymphoma: five-year follow-up of Southwest Oncology Group Protocol S9911.

Authors:  Oliver W Press; Joseph M Unger; Rita M Braziel; David G Maloney; Thomas P Miller; Michael Leblanc; Richard I Fisher
Journal:  J Clin Oncol       Date:  2006-08-08       Impact factor: 44.544

2.  Radioimmunotherapy, a new breakthrough in the treatment of follicular non-Hodgkin's lymphoma: the European perspective.

Authors:  Jean-François Chatal
Journal:  Cancer Biother Radiopharm       Date:  2006-02       Impact factor: 3.099

3.  Treatment with yttrium 90 ibritumomab tiuxetan at early relapse is safe and effective in patients with previously treated B-cell non-Hodgkin's lymphoma.

Authors:  Christos Emmanouilides; Thomas E Witzig; Leo I Gordon; Katie Vo; Gregory A Wiseman; Ian W Flinn; Mohamed Darif; Russell J Schilder; Arturo Molina
Journal:  Leuk Lymphoma       Date:  2006-04

4.  Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma.

Authors:  Thomas E Witzig; Leo I Gordon; Fernando Cabanillas; Myron S Czuczman; Christos Emmanouilides; Robin Joyce; Brad L Pohlman; Nancy L Bartlett; Gregory A Wiseman; Norman Padre; Antonio J Grillo-López; Pratik Multani; Christine A White
Journal:  J Clin Oncol       Date:  2002-05-15       Impact factor: 44.544

Review 5.  Antibody pretargeting advances cancer radioimmunodetection and radioimmunotherapy.

Authors:  David M Goldenberg; Robert M Sharkey; Giovanni Paganelli; Jacques Barbet; Jean-François Chatal
Journal:  J Clin Oncol       Date:  2005-12-27       Impact factor: 44.544

6.  Radioimmunotherapy of non-Hodgkin's lymphoma with 90Y-DOTA humanized anti-CD22 IgG (90Y-Epratuzumab): do tumor targeting and dosimetry predict therapeutic response?

Authors:  Robert M Sharkey; Arnold Brenner; Jack Burton; George Hajjar; Stephen P Toder; Abass Alavi; Alexander Matthies; Donald E Tsai; Stephen J Schuster; Edward A Stadtmauer; Myron S Czuczman; Dominick Lamonica; Françoise Kraeber-Bodere; Beatrice Mahe; Jean-François Chatal; André Rogatko; George Mardirrosian; David M Goldenberg
Journal:  J Nucl Med       Date:  2003-12       Impact factor: 10.057

7.  Predictive value and diagnostic accuracy of F-18-fluoro-deoxy-glucose positron emission tomography treated grade 1 and 2 follicular lymphoma.

Authors:  Shrinivas Bishu; Joanna M Quigley; Shreenath R Bishu; Sarah M Olsasky; Richard A Stem; Valerie K Shostrom; Karen P Holdeman; Subash Paknikar; James O Armitage; Jordan H Hankins
Journal:  Leuk Lymphoma       Date:  2007-08

8.  Phase II trial of a transplantation regimen of yttrium-90 ibritumomab tiuxetan and high-dose chemotherapy in patients with non-Hodgkin's lymphoma.

Authors:  Amrita Krishnan; Auayporn Nademanee; Henry C Fung; Andrew A Raubitschek; Arturo Molina; Dave Yamauchi; Roberto Rodriguez; Ricardo T Spielberger; Peter Falk; Joycelynne M Palmer; Stephen J Forman
Journal:  J Clin Oncol       Date:  2007-11-19       Impact factor: 44.544

9.  Comparison of 90Y-ibritumomab tiuxetan and 131I-tositumomab in clinical practice.

Authors:  Heather A Jacene; Ross Filice; Wayne Kasecamp; Richard L Wahl
Journal:  J Nucl Med       Date:  2007-10-17       Impact factor: 10.057

10.  Treatment of B cell malignancies with 131I Lym-1 monoclonal antibodies.

Authors:  S J DeNardo; G L DeNardo; L F O'Grady; E Hu; V M Sytsma; S L Mills; N B Levy; D J Macey; C H Miller; A L Epstein
Journal:  Int J Cancer Suppl       Date:  1988
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.